Floatz logo

IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER

Gastrointestinal Cancer

NantBioScience, Inc.monoclonal_antibodyPhase 1/2Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

73 Active assets in the Gastrointestinal Cancer cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Alliance for Clinical Trials in Oncology
Phase 2BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Brian Anderson, MD
Phase 4BB
Irinotecan
Amgen
Phase 2BB
DEXAMETHASONE
Cedars-Sinai Medical Center
Phase 4BB
Mlf 541
B. Braun Melsungen AG
Phase 3BB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER is also rated in:

pancreatic adenocarcinomaDormant
B
Indicative ·
62 / 100
View asset →
malignant pancreatic neoplasmDormant
B
Indicative ·
58 / 100
View asset →
metastatic neoplasmDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →